Affichage 61 à 61 des 61 essais cliniques
1 | 2 | 3 | 4 | 5 | 6 | 7 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C
CodeBreaK 202 NCT05920356  Actif en recrutement
|
INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUEBEC - UL |
Brigitte Fortin 418-656-8711 poste 2639 Marie-Ève Morneau 418-656-8711 poste 2690 |
Groupe d'étude en oncologie du Québec